| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/22/2001 | CA2377133A1 Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| 02/21/2001 | EP1076659A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders |
| 02/21/2001 | EP1076650A1 Aryl fused azapolycyclic compounds |
| 02/21/2001 | EP1076644A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/21/2001 | EP1076563A1 Dipeptide caspase inhibitors and the use thereof |
| 02/21/2001 | CN1284952A Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 02/21/2001 | CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284882A Beta-lipotropin and uses thereof |
| 02/21/2001 | CN1284876A Insoluble compositions for controlling blood glucose |
| 02/21/2001 | CN1284874A 5-HT1F agonists |
| 02/21/2001 | CN1284872A Treatment agent |
| 02/21/2001 | CN1284865A Pharmaceutical compositions containing micronized bicyclic drugs |
| 02/21/2001 | CN1284478A 营养水 Nutrition, water |
| 02/21/2001 | CN1284364A Production process of diabetes treating medicine |
| 02/21/2001 | CN1284351A Red sage containing medicine composition and its preparation and use |
| 02/21/2001 | CN1284344A Diabetes eliminating bolus |
| 02/21/2001 | CN1284331A Application of 5,3',5'-trihydroxy-methoxyl dihydroflavone in preparing medicine |
| 02/21/2001 | CN1062174C Method for preparing plant full natural nutrient solution and its product |
| 02/21/2001 | CN1062154C Method for producing chinese patent medicine and its pill for curing diabetes |
| 02/21/2001 | CN1062143C Medicinal health liquid and beer, beverage, beet and instant noodle containing the same |
| 02/20/2001 | US6191293 Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
| 02/20/2001 | US6191172 Used in drugs and cosmetics |
| 02/20/2001 | US6191163 Anticonvulsant derivatives useful in lowering lipids |
| 02/20/2001 | US6191160 Spiro-indolines as Y5 receptor antagonists |
| 02/20/2001 | US6191147 Pyrazole compounds and uses thereof |
| 02/20/2001 | US6191137 Pharmaceutical composition for oral administration |
| 02/20/2001 | US6191130 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5T H1A receptors |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190665 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof |
| 02/20/2001 | CA2302629C Estrogen receptor |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/20/2001 | CA2158991C Adipocyte differentiation inhibiting peptide and adipocyte differentiation inhibiting agent using the peptide as active component thereof |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001010989A1 Fat compositions |
| 02/15/2001 | WO2001010865A1 p38MAP KINASE INHIBITORS |
| 02/15/2001 | WO2001010847A2 Novel integrin receptor antagonists |
| 02/15/2001 | WO2001010829A1 Novel vitamin d analogues |
| 02/15/2001 | WO2001010813A1 Crystals of the sodium salt of pravastatin |
| 02/15/2001 | WO2001010463A1 Pastes with the sustained release of osteogenesis promoter |
| 02/15/2001 | WO2001010451A1 Remedies for diabetes |
| 02/15/2001 | WO2001010444A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | WO2001010420A1 Transdermal patch comprising methylphenidate |
| 02/15/2001 | WO2001010413A2 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | WO2001010381A2 Methods for treating or preventing pain and anxiety |
| 02/15/2001 | WO2001010221A1 Vaccines for the treatment of autoimmune disease |
| 02/15/2001 | WO2000068385A3 Novel nucleic acids and proteins with growth hormone activity |
| 02/15/2001 | WO2000066584B1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000059513A8 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1α, 25-DIHYDROXY VITAMIN D¿3? |
| 02/15/2001 | WO2000059483A3 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |
| 02/15/2001 | DE19937350A1 Treating C1q-esterase inhibitor protein synthesis disorders, especially angioneurotic edema, using tibolone, without androgenic and virilization side-effects |
| 02/15/2001 | DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381910A1 Novel vitamin d analogues |
| 02/15/2001 | CA2381215A1 P38map kinase inhibitors |
| 02/15/2001 | CA2379977A1 Novel integrin receptor antagonists |
| 02/15/2001 | CA2379335A1 Crystals of the sodium salt of pravastatin |
| 02/15/2001 | CA2379302A1 Therapeutic agent for diabetes |
| 02/15/2001 | CA2378486A1 Osteogenesis promoter sustained-release paste |
| 02/15/2001 | CA2378481A1 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | CA2378285A1 Vaccines for the treatment of autoimmune disease |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/14/2001 | EP1076066A1 Peptides for lowering blood glucose levels |
| 02/14/2001 | EP1076062A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 02/14/2001 | EP1075528A1 Endothelin-converting-enzyme like protein |
| 02/14/2001 | EP1075494A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075478A1 Phenylurea and phenylthio urea derivatives |
| 02/14/2001 | EP1075475A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
| 02/14/2001 | EP1075467A1 Pyrazole derivatives as p-38 map kinase inhibitors |
| 02/14/2001 | EP1075272A1 Methods for treating diabetes by inhibiting gdf-8 |
| 02/14/2001 | EP1075260A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 02/14/2001 | EP1075259A1 Novel fatty analogues for the treatment of diabetes |
| 02/14/2001 | EP1075258A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 02/14/2001 | EP1075256A1 Arylhydrocarbon receptor ligand antagonists |
| 02/14/2001 | EP1075191A1 Phytosterol compositions |
| 02/14/2001 | EP0968226A4 G-rich oligo aptamers and methods of modulating an immune response |
| 02/14/2001 | EP0643071B1 Compound for inhibiting bone resorption and accelerating osteogenesis |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/14/2001 | CN1283623A 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 02/14/2001 | CN1283622A 6-hydroxy-3(4-[2-(piperidine-1-group)oxyethyl group]phenoxy)-2-(4-methoxy phenyl) benzo[b] thiophene hydrochloride salt |
| 02/14/2001 | CN1283497A Oral liquid for treating cerebrovascular disease and its preparing process |
| 02/14/2001 | CN1283490A Defatting tea |
| 02/14/2001 | CN1283478A 'Yidaosheng' capsules |
| 02/14/2001 | CN1283477A 'Yanming' capsules for clearing eyes |
| 02/14/2001 | CN1283476A 'Qingzhang Hingmu' pills for clearing eyes |
| 02/14/2001 | CN1283475A Hypoglycemic capsules |
| 02/14/2001 | CN1283474A Medical pills for treating diabets |
| 02/14/2001 | CN1283454A Method for preparing pellet contg fat-soluble substances |
| 02/14/2001 | CN1283447A Locally-used weight reducing face-care compsns. |
| 02/13/2001 | US6187820 Administering compounds such as n,n-dimethyl-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutylamine hydrochloride for prophylaxis or treatment of hyperlipidemia, hypercholesterolemia or hypertriglyceridemia |
| 02/13/2001 | US6187809 Beta-3 adrenaline receptor agonist drugs for the treatment of diabetes, obesity, and hyperlipemia; 2-(n-(2-(dibenzofuran-3-yloxy)ethyl)amino)-1-phenylethanol, for example |
| 02/13/2001 | US6187805 Indole and indoline derivatives as 5-HT6 selective ligands |